Analyst James Sidoti works at SIDOTI and is focused on the Healthcare sector with 13 price targets and ratings documented since 2016 spanning on 2 stocks. Analyst's average stock valuation to be materialised ratio is 50% with an average time for price targets to be met of 85.5 days.
Most recent stock forecast was given on CODX, Co-Diagnostics, Inc at 12-Aug-2022.
James Sidoti best performing recommendations are on LMAT (LEMAITRE VASCULAR, INC).
The best stock recommendation documented was for LMAT (LEMAITRE VASCULAR, INC) at 9/22/2016. The price target of $23 was fulfilled within 56 days with a profit of $3.63 (18.74%) receiving and performance score of 3.35.
Average potential price target upside
Currently, out of the existing stock ratings of James Sidoti - 462 which are a Buy (59.46%), 315 which are a Hold (40.54%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
3
$1.6 (114.29%)
6
8 days ago
1/9 (11.11%)
$7.61 (94.16%)
65
Hold
5
$3.6 (257.14%)
14
7 months 16 days ago
0/2 (0%)
$2.72 (32.90%)
Buy
15
$11.53 (332.28%)
1 years 4 months 16 days ago
1/4 (25%)
$12.53 (91.93%)
65
Hold
20
1 years 11 months 27 days ago
2/3 (66.67%)
$7.2 (66.97%)
42
